170 related articles for article (PubMed ID: 31506148)
21. Frequency of the ETV6-RUNX1, BCR-ABL1, TCF3-PBX1, and MLL-AFF1 fusion genes in Guatemalan pediatric acute lymphoblastic leukemia patients and their ethnic associations.
Carranza C; Granados L; Morales O; Jo W; Villagran S; Tinti D; Villegas M; Antillón F; Torselli S; Silva G
Cancer Genet; 2013 Jun; 206(6):227-32. PubMed ID: 23859904
[TBL] [Abstract][Full Text] [Related]
22. [Clinical features and prognosis of children with acute lymphoblastic leukemia and different platelet levels].
Zhang AL; Chen XJ; Zou Y; Yang WY; Guo Y; Wang SC; Zhang L; Liu XM; Ruan M; Liu TF; Qi BQ; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2019 Aug; 21(8):766-771. PubMed ID: 31416500
[TBL] [Abstract][Full Text] [Related]
23. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
[TBL] [Abstract][Full Text] [Related]
24. [Therapeutic Outcomes of 28 ALL Patients with MLL Gene Rearrangement].
Wang SC; Chen XJ; Liu XM; Ruan M; Guo Y; Yang WY; Zhang L; Zou Y; Zhu XF; Chen YM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):359-364. PubMed ID: 32319363
[TBL] [Abstract][Full Text] [Related]
25. Childhood near-tetraploid acute lymphoblastic leukemia: an EGIL study on 36 cases.
Lemez P; Attarbaschi A; Béné MC; Bertrand Y; Castoldi G; Forestier E; Garand R; Haas OA; Kagialis-Girard S; Ludwig WD; Matutes E; Mejstríková E; Pages MP; Pickl W; Porwit A; Orfao A; Schabath R; Starý J; Strobl H; Talmant P; van't Veer MB; Zemanová Z;
Eur J Haematol; 2010 Oct; 85(4):300-8. PubMed ID: 20561032
[TBL] [Abstract][Full Text] [Related]
26. Excellent outcome of acute lymphoblastic leukaemia with TCF3-PBX1 rearrangement in Hong Kong.
Lin A; Cheng FWT; Chiang AKS; Luk CW; Li RCH; Ling ASC; Cheuk DKL; Chang KO; Ku D; Lee V; Ha SY; Li CK
Pediatr Blood Cancer; 2018 Dec; 65(12):e27346. PubMed ID: 30051646
[TBL] [Abstract][Full Text] [Related]
27. Frequency and clinical impact of ETV6/RUNX1, AF4-MLL, and BCR/ABL fusion genes on features of acute lymphoblastic leukemia at presentation.
Ajuba IC; Madu AJ; Okocha C; Ibegbulam OG; Okpala I; Nna OE
Niger J Clin Pract; 2016; 19(2):237-41. PubMed ID: 26856288
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation of the efficacy of two successive protocols on pediatric acute lymphoblastic leukemia with E2A-PBX1 fusion gene].
Mei YY; Gao C; Cui L; Zhao XX; Zhao W; Li WJ; Wang KL; Jiang J; Zhang RD; Xie J; Shi HW; Wang B; Zhang YH; Ma XL; Zhou X; Wu MY; Li ZG
Zhonghua Er Ke Za Zhi; 2013 Jun; 51(6):467-71. PubMed ID: 24120066
[TBL] [Abstract][Full Text] [Related]
29. Clinical features and prognostic impact of TCF3-PBX1 in childhood acute lymphoblastic leukemia: A single-center retrospective study of 837 patients from China.
Jia M; Hu BF; Xu XJ; Zhang JY; Li SS; Tang YM
Curr Probl Cancer; 2021 Dec; 45(6):100758. PubMed ID: 34034913
[TBL] [Abstract][Full Text] [Related]
30. High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group.
Yanada M; Takeuchi J; Sugiura I; Akiyama H; Usui N; Yagasaki F; Kobayashi T; Ueda Y; Takeuchi M; Miyawaki S; Maruta A; Emi N; Miyazaki Y; Ohtake S; Jinnai I; Matsuo K; Naoe T; Ohno R;
J Clin Oncol; 2006 Jan; 24(3):460-6. PubMed ID: 16344315
[TBL] [Abstract][Full Text] [Related]
31. Clinical features, early treatment responses, and outcomes of pediatric acute lymphoblastic leukemia in China with or without specific fusion transcripts: a single institutional study of 1,004 patients.
Gao C; Zhao XX; Li WJ; Cui L; Zhao W; Liu SG; Yue ZX; Jiao Y; Wu MY; Li ZG
Am J Hematol; 2012 Nov; 87(11):1022-7. PubMed ID: 22911440
[TBL] [Abstract][Full Text] [Related]
32. [Comparison of the efficacy of two chemotherapy protocols for children with TEL-AML1[STBZ] fusion gene positive acute lymphoblastic leukemia].
Wang KL; Mei YY; Cui L; Gao C; Liu FF; Zhao XX; Li WJ; Jiang J; Zhang RD; Xie J; Shi HW; Wang B; Zhang YH; Ma XL; Wu MY; Zhou X; Li ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):285-90. PubMed ID: 24762993
[TBL] [Abstract][Full Text] [Related]
33. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
Lu XT
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
[TBL] [Abstract][Full Text] [Related]
34. [Prognostic factors of pediatric patients with Ph-positive acute lymphoblastic leukemia].
Xue YJ; Wu J; Zuo YX; Jia YP; Lu AD; Zhang LP
Zhonghua Xue Ye Xue Za Zhi; 2018 Mar; 39(3):219-224. PubMed ID: 29562467
[No Abstract] [Full Text] [Related]
35. ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy.
Bhojwani D; Pei D; Sandlund JT; Jeha S; Ribeiro RC; Rubnitz JE; Raimondi SC; Shurtleff S; Onciu M; Cheng C; Coustan-Smith E; Bowman WP; Howard SC; Metzger ML; Inaba H; Leung W; Evans WE; Campana D; Relling MV; Pui CH
Leukemia; 2012 Feb; 26(2):265-70. PubMed ID: 21869842
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of gene rearrangements in Mexican children with acute lymphoblastic leukemia: a population study-report from the Mexican Interinstitutional Group for the identification of the causes of childhood leukemia.
Bekker-Méndez VC; Miranda-Peralta E; Núñez-Enríquez JC; Olarte-Carrillo I; Guerra-Castillo FX; Pompa-Mera EN; Ocaña-Mondragón A; Rangel-López A; Bernáldez-Ríos R; Medina-Sanson A; Jiménez-Hernández E; Amador-Sánchez R; Peñaloza-González JG; de Diego Flores-Chapa J; Fajardo-Gutiérrez A; Flores-Lujano J; Rodríguez-Zepeda Mdel C; Dorantes-Acosta EM; Bolea-Murga V; Núñez-Villegas N; Velázquez-Aviña MM; Torres-Nava JR; Reyes-Zepeda NC; González-Bonilla C; Mejía-Aranguré JM
Biomed Res Int; 2014; 2014():210560. PubMed ID: 25692130
[TBL] [Abstract][Full Text] [Related]
37. [Prognostic factors for childhood acute non-mature B-lymphoblastic leukemia].
Jiang H; Gu LJ; Xue HL; Tang JY; Chen J; Pan C; Chen J; Xu C; Dong L; Zhou M
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun; 10(3):290-4. PubMed ID: 18554450
[TBL] [Abstract][Full Text] [Related]
38. [Therapeutic effectiveness of CCLG-97 protocol on standard-risk childhood acute lymphoblastic leukemia].
Xiao PF; Chai YH; Li JQ; He HL; Wang Y; Li ZP; He YX; Ji ZH
Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):486-9. PubMed ID: 16083544
[TBL] [Abstract][Full Text] [Related]
39. [Application of imatinib in BCR- ABL positive acute lymphoblastic leukemia treatment in the real world].
Wan YL; Wang Y; Liu BC; Liu X; Gong XY; Zhao XL; Wang TY; Jiang EL; Feng SZ; Han MZ; Qiu LG; Mi YC; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2016 Oct; 37(10):886-891. PubMed ID: 27801322
[TBL] [Abstract][Full Text] [Related]
40. Prognostically significant fusion oncogenes in Pakistani patients with adult acute lymphoblastic leukemia and their association with disease biology and outcome.
Sabir N; Iqbal Z; Aleem A; Awan T; Naeem T; Asad S; Tahir AH; Absar M; Hasanato RM; Basit S; Chishti MA; Faiyaz Ul-Haque M; Khalid AM; Sabar MF; Rasool M; Karim S; Khan M; Samreen B; Akram AM; Siddiqi MH; Shahzadi S; Shahbaz S; Ali AS; Mahmood A; Akram M; Saeed T; Saleem A; Mohsin D; Shah IH; Khalid M; Asif M; Iqbal M; Akhtar T
Asian Pac J Cancer Prev; 2012; 13(7):3349-55. PubMed ID: 22994759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
